Erin Quicker, OTD, OTR/L, CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 439 Channel Rd Ste 102, Lake Wylie, SC 29710 Phone: 803-746-7800 Fax: 803-746-7807 |
Melanie L Ange, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4877 Charlotte Hwy, Lake Wylie, SC 29710 Phone: 803-831-9900 Fax: 803-831-2616 |
Ms. Pamela Corpus Paguio, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 252 Latitude Ln Ste 103, Lake Wylie, SC 29710 Phone: 803-818-0218 |
Madison Elizabeth Harkey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 252 Latitude Ln Ste 103, Lake Wylie, SC 29710 Phone: 803-818-0218 |
Jennifer C Todd, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4877 Charlotte Hwy, Lake Wylie, SC 29710 Phone: 803-831-9900 Fax: 803-831-2616 |
Alka Shirish Pathak, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4877 Charlotte Hwy, Lake Wylie, SC 29710 Phone: 803-831-9900 Fax: 803-831-2616 |
News Archive
DestinationRx, Inc., a leading provider of healthcare comparison tools, technology and data, today announced a strategic decision to rename the company DRX. The change in branding is a response to the company's significant growth in the healthcare industry—from its origins in prescription drug pricing and purchasing technology to its expansion into broader drug and health plan comparison technology and data services.
A costly and widely used mammography add-on increases detection of noninvasive and early-stage invasive breast cancer but also makes more mistakes than mammography alone, researchers from UC Davis and the University of Washington have found.
U-Systems, the leader in automated breast ultrasound, launched a revolutionary new transducer technology designed to deliver unparalleled imaging performance and patient comfort. Reverse-Curve Crystal™ (RCC) Transducer Technology was designed and optimized for use with the U-Systems' somo•v® Automated Breast Ultrasound (ABUS) system.
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.
Alcon, Inc. has announced that it has filed the second portion of its "rolling" New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for RETAANE® 15mg (anecortave acetate for depot suspension)
› Verified 5 days ago